Gesynta Pharma

Developer of oral therapies for treating chronic inflammatory conditions

placeSolna, Stockholm County, Sweden calendar_todayFounded 2017 groups11 employees language gesynta.se

Innovation

5 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 44 times.

YearFilings
20172
20181
20192
20201
20211
20222
20241
20252

Social engagement

Social engagement: 2.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Industrifonden, Hadean Ventures.

Investor typeCountShare
Venture capital3100%

Recent activity

2 Jul 2026
Event
Women's Health Week Europe 2026
17 Jun 2026
Milestone
regulatory
14 May 2026
Event
BIO International
Coming soon